Searched for
SPECIALTY INSURANCE
Zurich Insurance taps India to bolster AI, cyber insurance capabilitiesZurich Insurance Group is increasing its emphasis on AI and specialty insurance to manage emerging risks. The company aims to leverage its ...
These mid-caps have ‘strong buy’ and ‘buy’ recos and upside potential of over 25%, according to analystsMore than anything else, what is important in the stock market at this point of time is to avoid a hybrid model of thinking. What this basi...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%That market has seemingly shed the fear that was dominating it these past several months. However, even as a recovery takes place, it is no...
Insurance cover for robotic surgeries may expand as GIC reviews listThe General Insurance Council is focusing on expanding coverage for robotic-assisted surgeries for various conditions. It plans to periodic...
These large-, mid- and small-cap stocks have upside potential of more than 20% in 1 year, according to analystsThe probability of a sharp, damaging downturn now appears low, and the broad direction favours the market. So, the stance should be the sam...
These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystNo doubt, the mood in the market has changed and the bulls seem to be back in a determined fashion. Don’t, however, expect the indices to k...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%The FPIs that were selling in the Indian market all these months mostly owned large-cap stocks. And as they sold them, it was that segment ...
For long- and medium-term investors: Cycles turn, principles don’t; 5 large-cap stocks with upside potential of up to 29%These are the stocks that fell the most, so they may bounce back the most if the fund flows return. They are the ones FPI money will target...
These mid-caps have ‘strong buy’ & ‘buy’ recos and upside potential of up to 28%, according to analystsGlobal markets on Wednesday celebrated the outcome of the US mid-term election as well as a sharp drop in oil prices. Oil prices, which at ...
The business of running a hospital: Balancing profitability, patient trust and scaleA hospital’s financial health depends on more than occupancy and revenue, requiring a careful balance of cost control, cash flow and patien...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%Oil prices matter to the Indian economy, and the market responded with a smart rally as Brent crude cooled significantly on Monday. The ral...
After Louvre heist and string of thefts, Europe's smaller museums are on guardA recent theft at the Fondazione Magnani Rocca museum resulted in €9 million worth of stolen artworks. The incident reflects a broader tren...
Hospital balance sheet: How AI could cut costs and improve efficiencyAs hospitals grapple with soaring costs in drugs, supplies, and labor, the integration of AI emerges as a vital necessity.
Stocks in news: Paytm, Tata Consumer, Dalmia Bharat, REC and DCM ShriramIndian equity markets showed recovery with a rise in NSE Nifty 50, ending a four-session losing streak. Several companies reported their Se...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsAt this juncture, what companies say about their Q2 results, and their outlook for Q3 and Q4, matters a great deal – but only to a certain ...
These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsThe last few weeks have made one thing clear. Oil prices, US bond yields, corporate earnings, and the state of the world – all point the sa...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up 32%, according to analystsHistory tells us that there is no way you can time the markets or predict its movement. But one thing can certainly be said: If the macro m...
5 stocks with consistent score improvement and upside potential of up to 28% in 1 year, according to analystMultiple headwinds continue to hit the market, and there is no sign that things will change anytime soon. In these circumstances, the chanc...
The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reachFor millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe next few weeks are critical, and one should not be in a hurry to make market-related decisions. Better to be cautious – to wait and wat...